Month: December 2020

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1.         KEY INFORMATION2.         POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should...

 December 15, 2020Dear Shareholders and Investors,  Last week, the undersigned received an Award from the President of the Republic of Korea (South Korea) for our promotion of the country over the years.Our relationship with South Korea and other countries in Asia has always been important for NAT. We see this Award as a token of our work in the region. We are actively trading our ships in the East.Despite a temporary slowdown in the fourth quarter, we expect that 2020 will become a very good year for NAT. We see that the Asian economies are recovering rapidly. In particular to all our friends in the US, on behalf of Nordic American Tankers, I would like to take this opportunity to wish you all the best for Christmas and for a strong Tanker Year in 2021!Herbjorn HanssonFounder, Chairman & CEO Nordic American Tankers Ltd.         ...

Vi har beregnet de foreløbige men ureviderede udbytter for 2020, de fremgår af nedenstående skema.De forventede udbytter er foreløbige og kan ændre sig indtil årsskiftet.Udbytterne forventes udbetalt i slutningen af januar 2021ISIN                                                 Afdeling                                                                     kr. pr. andelDK0010157965                              Globale Aktier KL A                                                  39,50 kr.DK0060287217                             Globale Aktier Etik KL                                               14,00 kr.DK0010312529                             Stabile Aktier KL A                                                     6,60 kr.DK0015945166                             Emerging Markets KL                                                  0,00 kr.DK0060057644                            ...

ROCHESTER HILLS, Michigan, Dec. 15, 2020 (GLOBE NEWSWIRE) — InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today announced its net revenues, Adjusted EBITDA (non-GAAP), and operating cash flow annual guidance for the full year 2021. Full year 2021 refers to the 12-month period beginning on January 1, 2021 and ending on December 31, 2021.Management DiscussionRichard DiIorio, chief executive officer of InfuSystem, said, “Our business continues to exhibit strength and based on our confidence, I am pleased to provide full year 2021 guidance. We are projecting net revenues to be within the range of $107 million to $110 million, Adjusted EBITDA to be within...

LA JOLLA, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that MediciNova will be added to the NASDAQ Biotechnology Index (NASDAQ: NBI) effective prior to the market open on Monday, December 21, 2020.The NASDAQ Biotechnology Index (NBI) is designed to track the performance of a set of securities listed on the NASDAQ Stock Market® (NASDAQ®) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark. The addition of MediciNova to the NBI is a result of the annual reconstitution of the index.    The NASDAQ Biotechnology Index is the benchmark index for the iShares Nasdaq Biotechnology ETF (exchange-traded fund)...

See attachmentsAttachmentsVidskipti-fruminnherja-15.12.2020 – GUJVidskipti-fruminnherja-15.12.2020 – PH – saleVidskipti-fruminnherja-15.12.2020 – PHVidskipti-med-eigin-bref-15.12.2020 – buyVidskipti-med-eigin-bref-15.12.2020 – sell 2Vidskipti-med-eigin-bref-15.12.2020 – sell

Landfestar ehf. hefur greitt upp skuldabréfaflokkinn LF 14 1 í samræmi við tilkynningu í kauphöll, dags. 26. nóvember 2020. Skuldabréfin hafa verið afskráð.Nánari upplýsingar veitir:Lýður H. Gunnarsson, framkvæmdastjóri fjármálasviðs Eikar fasteignafélags hf., lydur@eik.is, s. 820-8980.

Los Angeles, CA, Dec. 15, 2020 (GLOBE NEWSWIRE) — Los Angeles, CA, December 15, 2020 (GLOBE NEWSWIRE) — KRONOS ADVANCED TECHNOLOGIES, INC., (OTC MARKETS: KNOS) (“KNOS” or the “Company”), a revenue-generating, product development and production company that has significantly changed the way air is moved, filtered and sterilized announced today that the Company applied for a tier upgrade to the OTCQB® Venture Markets.OTCQB® Venture Market is operated by the OTC Markets Group, Inc. and is designed for early-stage and developing U.S. and international companies, offering companies the opportunity to build visibility, expand liquidity and diversify their shareholder base. To be eligible for quotation on the OTCQB®, companies must meet certain SEC or alternative reporting requirements, maintain annual financials...